People: Biogen Idec Inc (BIIB.O)

BIIB.O on Nasdaq

342.40USD
26 Dec 2014
Price Change (% chg)

$1.51 (+0.44%)
Prev Close
$340.89
Open
$342.92
Day's High
$345.55
Day's Low
$338.02
Volume
1,138,728
Avg. Vol
1,723,124
52-wk High
$361.93
52-wk Low
$270.62

Search Stocks

Cox, John 

Brief Biography

Mr. John G. Cox is Executive Vice President - Pharmaceutical Operations and Technology of Biogen Idec Inc. Mr. Cox joined Biogen, Inc. in 2003 and has held several senior executive positions with us, including Senior Vice President of Technical Operations, Senior Vice President of Global Manufacturing, and Vice President of Manufacturing and General Manager of Biogen Idec’s operations in RTP. Prior to that, Mr. Cox held a number of senior operational roles at Diosynth Inc., a life sciences manufacturing and services company, where he worked in technology transfer, validation and purification. Prior to that, Mr. Cox focused on the same areas at Wyeth Corporation, a life sciences company, from 1993 to 2000. Mr. Cox serves on the board of directors of Repligen Corporation, a life sciences company. Mr. Cox received his B.S. in Biology from Arizona State University, M.B.A. from the University of Michigan and M.S. in Cell Biology from California State University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,216,920 -- 206,791 3,671,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 52,499 1,342,680.00
Name Fiscal Year Total

Stelios Papadopoulos

--

George Scangos

15,015,100

Paul Clancy

4,486,260

Kenneth Di Pietro

3,254,520

Susan Alexander

2,162,200

John Cox

3,671,600
As Of 30 Dec 2013
Search Stocks